1WILD S, ROGLIC G, GREEN A,et. al. Global prevalence of diabetes : estimates for the year 2000 and projections for 2030[ J ]. Diabet Care ,2004,27(5 ) : 1054 - 1073.
5DAVIS C M, VINCENT J B. Chromium oligopeptide activates insulin receptor tyrosine kinase activity[ J] . Biochem,1997,36(15) :4382 -4385
6ANDERSON R A, POLANSKY MIM, BRKDEN N A, et al. Chrom ium supplementationof human subject: effect on glucose tolerance, serum glucose , insulin, and lipid variables[J]. Metabolism,1983 ,32(9) :894-899
8Levine G E , Mather H M , Pickington T R. Tissue magneum status in diabetes mellitus [ J ]. Diabetologia , 1981 , 21 (2):131 -134.
9Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromiumimproved glucose and insulin variables in individuals with type 2diabetes[ J]. Diabetes,1997 ,46 (11) :1786.
10MACALL KA, HUANGC, FIERKE C A. Function and mechanism of zinc metalloenzymes [ J ] . J Nutr ,2000 , 130(5 Suppl) :1437S -1446S.
